Bharat Parenterals Ltd

EGM purpose

• EGM to seek shareholder approval for proposed preferential issue of equity shares.
• Corrigendum adds disclosure on Monitoring Agency due to issue size.

Resolution details

• Type: not disclosed; Nature: preferential issue of equity shares.
• Key term: Crisil Ratings Limited appointed as Monitoring Agency for proceeds use.
• Rationale: monitoring required when issue size exceeds INR 100 crore.
• Promoters/directors' interest: not specified in corrigendum.

Preferential allotment details

• Issuance of up to 9,12,759 equity shares at Rs 1,522.85 each for Rs 138.99 crore.
• Non-promoter investors; subject to shareholder and regulatory approvals.
• Annexure-1A sets out investors and post-allotment holdings.

EGM for approval

• EGM scheduled for 23 October 2026 at 11:30 AM via video conference.
• Shareholder approval for the preferential issue to be sought.

Investments in subsidiaries

• Investments or loans to subsidiaries planned to support development of existing and new projects.

Regulatory/compliance notes

• Subject to approvals under Companies Act 2013 and SEBI LODR.

Bharat Parenterals Limited: Trading Window closed from Oct 01, 2026 till completion of 48 hours after the declaration of Un-audited Financial Results for the quarter and half year ended September 30, 2026

AGM details

• AGM held Sep 19, 2026 via VC/OAVM from 11:00 to 11:30 IST.
• Record date 12-09-2026; total on-record shareholders 3,108.
• VC attendance: promoters 5, public 30.
• Six resolutions were put to vote; all passed.

Resolutions & outcomes

• Resolution 1: adoption of Audited Financial Statements; passed.
• Resolution 2: declare final dividend for year ended Mar 31, 2026; passed.
• Resolution 3: appoint Hemang Shah by rotation; reappointed as director; passed.
• Resolution 4: reappoint Hemang Shah as Executive Director; passed.
• Resolution 5: approve remuneration to CMA Chetan Gandhi for FY2027; passed.
• Resolution 6: approve related party transactions; passed.

Dividend

• Final dividend for FY ended 31 Mar 2026 approved; per-share amount not disclosed.

Director changes

• Hemang Shah reappointed as Executive Director following rotation.

Auditors / Remuneration

• Remuneration payable to CMA Chetan Gandhi, Cost Accountant, approved for FY ending Mar 31, 2027.

Related party transactions

• Related Party Transactions approved.

AGM Details

• AGM held on Sept 19, 2026 at 11:00 A.M. via VC/OAVM; concluded 11:30 A.M.

Key Resolutions

• Ordinary resolution: adopt audited financial statements for year ended March 31, 2026.
• Ordinary resolution: declare final dividend for year ended March 31, 2026.
• Ordinary resolution: re-appoint Hemang Shah after retirement by rotation.
• Ordinary resolution: re-appoint Hemang Shah as Executive Director.
• Ordinary resolution: approve remuneration for CMA Chetan Gandhi for FY ending March 31, 2027.
• Ordinary resolution: approve related party transactions.

Voting Outcome

• All resolutions deemed to be passed on the AGM date.

Shareholder communications & AGM notice

• Dispatched letters to shareholders with unregistered emails linking to FY2025-26 Annual Report and AGM notice.
• 33rd AGM scheduled for Sep 19, 2026 at 11:00 IST via VC/OAVM; venue deemed to be Registered Office.
• Annual Report for FY2025-26 available on the company's website and notices accessible there.
• Cut-off date for voting entitlement: Sep 12, 2026.
• Encourages email registration/update with depositories/RTA; dematerialization recommended for physical holders.
• Nominations and KYC forms available on the website.
• RTA contact email provided for queries.

Dividend record date

• Record date: September 12, 2026 for 2025-26 dividend.
• Type of security: Equity Shares.
• Dividend payable subject to approval by Members at AGM scheduled on 19,2026.
• Beneficial owners on the record date will be entitled to the dividend.